(SHLTN) S H L Telemedicine - Ratings and Ratios

SHL Telemedicine Ltd. (SW:SHLTN) is a global provider of innovative telemedicine solutions, operating in Israel, Europe, and international markets. The company specializes in developing and marketing personal telemedicine devices designed to enhance remote patient monitoring and improve cardiovascular health outcomes. Its product portfolio includes SmartHeart, a FDA-approved 12-lead ECG device enabling early detection of heart attacks; CardioSenC, a cellular-digital 12-lead ECG transmitter; and CardioB, a portable 12-lead ECG transmitter. Additionally, the company offers a central communication module that integrates data from various medical devices such as blood pressure monitors, oxygen saturation meters (TelePulse Oximeter), breath exhalation devices (TeleBreather), and glucose monitoring systems. TelePress, a remote blood pressure monitoring device, is also part of its product lineup. These solutions are complemented by telemedicine services delivered through advanced electronic and telecommunication technologies.

The company serves a diverse range of clients, including physicians, hospitals, health insurance funds, and patients. SHL Telemedicine has established strategic collaborations, notably with Mayo Clinic to study the impact of its SmartHeart device on reducing emergency department visits, re-hospitalizations, and major adverse cardiovascular events within 90 days of initial hospitalization for myocardial infarction. It also partners with the Hebrew University of Jerusalem and the Hadassah Medical Center to advance its research and clinical applications. Founded in 1986 and headquartered in Tel Aviv, Israel, the company has built a reputation for integrating cutting-edge technology with clinical excellence in the telemedicine sector. Web URL: https://www.shl-telemedicine.com

Ticker Symbol: SHLTN
Exchange: SW
Type: common stock
Country Origin: Israel
GICS Sub Industry: Health Care Technology

3-Month Forecast:
Average Volume 20d: 2431
Last Price: 2.40
SMA 20: 2.21
SMA 50: 2.45
SMA 200: 3.21
ATR: 0.16
Market Cap: 34.59M CHF
P/E: 0.00
P/E Forward: 0.00
P/B: 0.59
P/S: 0.62
RoE: -9.60

Technical Outlook: SHLTN is currently trading below its SMA 50 (2.45) but above its SMA 20 (2.21), suggesting short-term volatility. The SMA 200 (3.21) indicates a longer-term downtrend. With an ATR of 0.16, price fluctuations are expected to remain moderate.

Fundamental Analysis: The companys P/B ratio of 0.59 signals undervaluation relative to book value. However, the negative RoE of -9.60 raises concerns about profitability. A P/S ratio of 0.62 suggests reasonable valuation relative to sales.

3-Month Forecast: Expect SHLTN to trade in a narrow range between 2.10 and 2.70, driven by technical resistance at SMA 50 and support at SMA 20. Fundamental trends may remain neutral unless profitability improves.